Clenbuterol ingestion causing prolonged tachycardia, hypokalemia, and hypophosphatemia with confirmation by quantitative levels.
about
Toxicity of weight loss agentsDose-effects of aorta-infused clenbuterol on spinal cord ischemia-reperfusion injury in rabbits.Beta2 adrenergic agonist, clenbuterol, enhances working memory performance in aging animals.Is postural tremor size controlled by interstitial potassium concentration in muscle?Acute clenbuterol overdose resulting in supraventricular tachycardia and atrial fibrillation.Roles and potential therapeutic targets of the ubiquitin proteasome system in muscle wasting.Adverse effects from clenbuterol and ractopamine on nematode Caenorhabditis elegans and the underlying mechanism.Alternative drugs of abuse.Selection of a representative matrix for the multiresidue analysis of nine β-agonists in animal tissues and urine with LC-MS/MS.A novel neuromuscular syndrome associated with clenbuterol-tainted heroin.Food poisoning by clenbuterol in Portugal.Acute clenbuterol induces hypotension, atrioventricular block and cardiac asystole in the rabbit.Case of low dose clenbuterol toxicity.Clenbuterol Attenuates hERG Channel by Promoting the Mature Channel Degradation.Unsuspected Clenbuterol Toxicity in a Patient Using Intramuscular Testosterone.
P2860
Q34255825-815EA5CD-E757-4186-97DD-4EB13E4A260CQ35082807-B9717566-E156-4A95-8A9D-B3F5BD195B58Q35157911-4734C292-A04D-4F5C-A6CE-9F683FA2C1ACQ35481918-970A0B1D-D8C4-4731-9172-EED6B8D1F9DBQ36548523-7FB28FC3-4FB4-464B-9BB8-CC581ED95C00Q37019253-0B7301A1-9391-4AE9-BB19-D3E849BAFB8BQ37499376-32D7A622-EDD1-4556-8272-308DED3459CEQ38103475-4BE9EB9B-4F55-4517-A1E3-6FBFF905FB09Q44097462-441EB8C8-C69A-40BA-AF25-7378A6B13C83Q46240770-353758E6-5F33-401B-B380-9B0ED6F19F9EQ46600939-2C5284FD-8661-4ADB-87DD-AA6A3AC10D94Q46809257-A9CCB3B4-88CB-4EBC-A1A0-7499EE2AD775Q47440286-8DD7188A-CE78-44CD-B2AE-95B9A7AC1A33Q50628884-E0EC114F-6716-4BE3-9C48-12461C9CD07FQ55113171-8DF38069-8AF2-46E4-B953-119E0A6DC014
P2860
Clenbuterol ingestion causing prolonged tachycardia, hypokalemia, and hypophosphatemia with confirmation by quantitative levels.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Clenbuterol ingestion causing ...... mation by quantitative levels.
@en
Clenbuterol ingestion causing ...... mation by quantitative levels.
@nl
type
label
Clenbuterol ingestion causing ...... mation by quantitative levels.
@en
Clenbuterol ingestion causing ...... mation by quantitative levels.
@nl
prefLabel
Clenbuterol ingestion causing ...... mation by quantitative levels.
@en
Clenbuterol ingestion causing ...... mation by quantitative levels.
@nl
P2093
P2860
P356
P1476
Clenbuterol ingestion causing ...... mation by quantitative levels.
@en
P2093
C L Freyberg
R H Poppenga
R J Hoffman
R S Hoffman
P2860
P304
P356
10.1081/CLT-100105152
P577
2001-01-01T00:00:00Z